Join Hands to Build a Smarter India: Sign in | Join now
News

India Continues To Be Hub for Clinical Trials

By SiliconIndia  |   Monday, 27 May 2013, 03:09 Hrs   |    2 Comments
28
29
38
8
Print Email


Bangalore: Around 2,644 people died during the clinical trials of 475 new drugs in last seven years and merely 17 of the medicines were approved for marketing in India, said the Centre to the Supreme Court, reported Dhananjay Mahapatra for TNN.

Health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare "Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," as reported by TNN.

He added that "Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials."

It was also noted that drug trial of two drugs - Bayer's Rivaroxaban and Novartis's Aliskiren vs. Enalapril – made up for maximum number of deaths. Further, majority of the pharmaceutical companies, whose drugs were allowed for clinical trial on human beings were of foreign origin.

While clinical trials were to be banned for new drugs on humans, additional solicitor general Siddharth Luthra had pulled out the government from taking that decision and said that the health secretary would personally monitor implementation of the new stricter regime.

Also Read: India's Drug Trials Industry Threatened Due To Slow Approvals
Also Read: India Ranks Second In Research among BRICK Nations



Experts on SiliconIndia
Sunil  Bhat
Project Management
HCL Infosystems Limi
Haresh  Motirale
Founder Director
Brandniti
Jeya  Padmanaban
President
JP Research, Inc.
Sonal  Rochani
President
Shakti Foundation
Chetan  Nagaonkar
Managing Director
eStomi Technologies
Deepak  Gupta
Business Analyst
Wipro Technologies
Sarvesh  Vaidya
Senior Director - HR
Tangoe
Aarthi  G R
HRM Specialist
PlasmaGen
Sign Up for DailyDose and Read the Day's Highlights
Write your comment now
 
Reader's comments(2)
1: These clinical trials should be in INDIA. Foreign drug companies should do these trials in their own countries and not use Indian ignorant people as guinea pigs as they have used other minorities in their own country in the past.
Posted by:rajkumar gupta - 29 Jul, 2013
2:
These trials should not be done in India.
rajkumar gupta Replied to: rajkumar gupta - 29 Jul, 2013
SPOTLIGHT
SiliconIndia About Us   |   Contact Us   |   Help   |   Community rules   |   Advertise with us   |   Sitemap   |  
News:       Technology   |   Enterprise   |   Gadgets   |   Startups   |   Finance   |   Business   |   Career   |   Magazine  |   Newsletter   |   News archive  
Cities:        CEO   |     Startup   |   Mobile   |   CIO   |   Women   |   BI   |   HR   |   SME   |   Cloud   |   Marketing   |   QA   |   Java   |   Web Developer  
Community:      Members   |   Blogs   |   Indian Entrepreneurs   |   Gyan   |   Advice   |   Community   |   Find   |   Events   |   CXO Insights  
Job Board:      Jobs   |   Freshers   |   Companies   |   HR Speak   |   Forum  
Online Courses:   Web Developer   |   Java Developer   |   CCNA Training   |   SEO   |   SAS   |   SQL Server 2005   |   J2EE
Education:   MBA   |   MCA   |   Engineering   |   Training Institute
Life:          Real Estate   |   Travel   |   Finance   |   Gadgets   |   Movie Reviews   |    Jokes  
Send your feedback and help us continue to improve SiliconIndia
© 2014 InfoConnect Web Technologies India Pvt Ltd. all rights reserved